載入...
Phase 1 Trial of the Plasmodium falciparum Blood Stage Vaccine MSP1(42)-C1/Alhydrogel with and without CPG 7909 in Malaria Naïve Adults
BACKGROUND: Merozoite surface protein 1(42) (MSP1(42)) is a leading blood stage malaria vaccine candidate. In order to induce immune responses that cover the major antigenic polymorphisms, FVO and 3D7 recombinant proteins of MSP1(42) were mixed (MSP1(42)-C1). To improve the level of antibody respons...
Na minha lista:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Public Library of Science
2010
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2809736/ https://ncbi.nlm.nih.gov/pubmed/20107498 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0008787 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|